Jardiance is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health. The primary component is Empagliflozin.
Product ID | 55154-0411_28f5b18c-9d41-469f-83f7-b761623fc7bb |
NDC | 55154-0411 |
Product Type | Human Prescription Drug |
Proprietary Name | Jardiance |
Generic Name | Empagliflozin |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2014-08-01 |
Marketing Category | NDA / NDA |
Application Number | NDA204629 |
Labeler Name | Cardinal Health |
Substance Name | EMPAGLIFLOZIN |
Active Ingredient Strength | 10 mg/1 |
Pharm Classes | Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2014-08-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA204629 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-08-01 |
Ingredient | Strength |
---|---|
EMPAGLIFLOZIN | 10 mg/1 |
SPL SET ID: | 5777b8a8-ada6-4950-8548-43a1de11f075 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0597-0152 | Jardiance | Empagliflozin |
0597-0153 | Jardiance | Empagliflozin |
50090-4384 | Jardiance | Empagliflozin |
50090-4492 | Jardiance | Empagliflozin |
55154-0411 | Jardiance | Empagliflozin |
55154-0412 | Jardiance | Empagliflozin |
70518-1986 | Jardiance | Empagliflozin |
70518-2447 | Jardiance | Empagliflozin |
71610-177 | Jardiance | Empagliflozin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
JARDIANCE 88902811 not registered Live/Pending |
Boehringer Ingelheim International GmbH 2020-05-06 |
JARDIANCE 79060588 3595152 Live/Registered |
Boehringer Ingelheim International GmbH 2008-09-03 |